HomeREGULATORY
REGULATORY

MHLW OKs Add’l Indications for Revolade, Actemra and More
(Aug.28.2017)

The Ministry of Health, Labor and Welfare (MHLW) on August 25 approved additional indications for a batch of drugs including Novartis Pharma’s Revolade (eltrombopag) and Chugai Pharmaceutical’s Actemra (tocilizumab) ...
(LOG IN FOR FULL STORY)